Roche N-C, Stefuriac M, Dumitrescu N, Charbonnel A, Godreuil C, Bonnevie L
Service de cardiologie, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.
Service de cardiologie, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
Implantable cardioverter defibrillator (ICD) is well-recognized therapy to prevent sudden cardiac death. Classic ICD need the use of permanent endocavitary leads, which may cause serious troubles (lead dislodgement, ventricular perforation, lead infections, etc.). The subcutaneous implantable cardioverter defibrillator (S-ICD) is a new device provided by only a subcutaneous lead. It has been developed for the last five years and it is becoming at present a real alternative to classic ICD. We report a clinical case of a 34 y.o. woman who presented a sudden cardiac death and who benefited the implantation of this new technology. This paper deals with the potential indications, usefulness benefits, and problems of the S-ICD.
植入式心脏复律除颤器（ICD）是预防心源性猝死的公认疗法。传统ICD需要使用永久性心腔内导线，这可能会引发严重问题（导线移位、心室穿孔、导线感染等）。皮下植入式心脏复律除颤器（S-ICD）是一种仅配备皮下导线的新设备。它在过去五年中得到了发展，目前正成为传统ICD的一种切实可行的替代方案。我们报告了一例34岁女性的心源性猝死临床病例，该患者受益于这项新技术的植入。本文探讨了S-ICD的潜在适应症、效用益处及问题。
